I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| dendritic cell | 7 studies | 40% ± 15% | |
| plasmacytoid dendritic cell | 7 studies | 36% ± 8% | |
| classical monocyte | 6 studies | 24% ± 7% | |
| natural killer cell | 6 studies | 34% ± 11% | |
| CD4-positive, alpha-beta T cell | 6 studies | 19% ± 4% | |
| non-classical monocyte | 5 studies | 30% ± 6% | |
| conventional dendritic cell | 5 studies | 32% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 29% ± 8% | |
| naive B cell | 4 studies | 27% ± 7% | |
| CD8-positive, alpha-beta T cell | 4 studies | 31% ± 9% | |
| mucosal invariant T cell | 4 studies | 21% ± 3% | |
| macrophage | 4 studies | 19% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 28% ± 8% | |
| mast cell | 4 studies | 25% ± 5% | |
| mature NK T cell | 4 studies | 18% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 24% ± 8% | |
| common myeloid progenitor | 3 studies | 26% ± 7% | |
| regulatory T cell | 3 studies | 28% ± 7% | |
| endothelial cell | 3 studies | 20% ± 2% | |
| monocyte | 3 studies | 29% ± 11% | |
| gamma-delta T cell | 3 studies | 23% ± 1% | |
| plasmablast | 3 studies | 28% ± 7% |
